SUBSCRIBE TO OUR NEWSLETTER

Resources

12 October 2021

Reporting on a Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-satoreotide Trizoxetan As An Imaging Agent in Gastroenteropancreatic Neuroendocrine Tumors
5 October 2021

Get to Know Andrew Salzman, M.D., Partner and Consultant with The Bracken Group

27 September 2021

Why Readers Vary in Interpreting Clinical Trial Images, and When to Worry About It
9 September 2021

Andrew L. Salzman, MD, Joins The Bracken Group

22 July 2021

TBG’s Katie Diaz Assumes Committee Chairperson Role with Women In Biotech

20 July 2021

30 Year History of the Imaging Core Lab Industry
29 June 2021

Chelsea Miller Adds New Breadth to TBG Expertise in Regulatory Affairs

15 June 2021

Entrepreneurs, Take Time to Understand and Appreciate the Impact of Regulatory Affairs and Authorities

8 June 2021

For Success with Imaging in RA Clinical Trials, Consult with Experts in Both the Disease and the Technology 
20 May 2021

The Bracken Group’s Inhouse Physician Talks Translational Medicine

CONTACT US

Ask us anything.

We would be delighted to hear from you and discuss our consulting services. Please call +1 215 648 1208 to chat with us directly. Or write to us using the form provided here. We look forward to collaborating with you.
It's almost like getting free consulting...

Subscribe to our monthly hand-crafted newsletter for the latest insights on clinical trial trends and the life science industry.

Subscribe Now  

12 Penns Trail, Newtown, PA 18940
+1 215 648 1208

© 2022 the bracken group - Privacy Policy

12 Penns Trail, Newtown, PA 18940
+1 215 648 1208

© 2022 the bracken group - Privacy Policy